HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris.

AuthorsDaniel Soffer, Issam Moussa, Murat Karatepe, Kishore J Harjai, Judith Boura, Simon R Dixon, Cindy L Grines, William W O'Neill, Gary S Roubin, Jeffrey W Moses
JournalThe American journal of cardiology (Am J Cardiol) Vol. 91 Issue 7 Pg. 872-5 (Apr 01 2003) ISSN: 0002-9149 [Print] United States
PMID12667576 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Adrenergic beta-Antagonists
  • Fibrinolytic Agents
  • Nitrates
  • Platelet Aggregation Inhibitors
  • Tyrosine
  • Heparin
  • Tirofiban
Topics
  • Adrenergic beta-Antagonists (therapeutic use)
  • Aged
  • Angina, Unstable (therapy)
  • Angioplasty, Balloon, Coronary
  • Cohort Studies
  • Female
  • Fibrinolytic Agents (therapeutic use)
  • Heparin (therapeutic use)
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Nitrates (therapeutic use)
  • Observer Variation
  • Platelet Aggregation (drug effects)
  • Platelet Aggregation Inhibitors (therapeutic use)
  • Platelet Count
  • Tirofiban
  • Treatment Outcome
  • Tyrosine (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: